» Articles » PMID: 24497737

Effect of Standardized Aqueous Extract of Withania Somnifera on Tests of Cognitive and Psychomotor Performance in Healthy Human Participants

Overview
Date 2014 Feb 6
PMID 24497737
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Withania somnifera is an herbal medicine that has been known to possess memory-enhancing properties. The current study involved an assessment of cognitive and psychomotor effects of Withania somnifera extract in healthy human participants.

Materials And Methods: In this prospective, double-blind, multi-dose, placebo-controlled, crossover study, 20 healthy male participants were randomized to receive 250 mg two capsules twice daily of an encapsulated dried aqueous extract of roots and leaves of Withania somnifera or a matching placebo for a period of 14 days. Cognitive and psychomotor performance was assessed pre-dose (day 1) and at 3 hrs post-dose on day 15 using a battery of computerized psychometric tests. After a washout period of 14 days, the subjects crossed-over to receive the other treatment for a further period of 14 days as per prior randomization schedule. Same battery of test procedures were performed to assess cognitive and psychomotor performance.

Results: Significant improvements were observed in reaction times with simple reaction, choice discrimination, digit symbol substitution, digit vigilance, and card sorting tests with Withania somnifera extract compared to placebo. However, no effect can be seen with the finger tapping test.

Conclusion: These results suggest that Withania somnifera extract can improve cognitive and psychomotor performance and may, therefore, be a valuable adjunct in the treatment of diseases associated with cognitive impairment.

Citing Articles

Plants' Impact on the Human Brain-Exploring the Neuroprotective and Neurotoxic Potential of Plants.

Moise G, Jijie A, Moaca E, Predescu I, Dehelean C, Heghes A Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458980 PMC: 11510325. DOI: 10.3390/ph17101339.


Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.

Leonard M, Dickerson B, Estes L, Gonzalez D, Jenkins V, Johnson S Nutrients. 2024; 16(12).

PMID: 38931168 PMC: 11207027. DOI: 10.3390/nu16121813.


(L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review.

Lerose V, Ponticelli M, Benedetto N, Carlucci V, Lela L, Tzvetkov N Plants (Basel). 2024; 13(6).

PMID: 38592845 PMC: 10976061. DOI: 10.3390/plants13060771.


Effects of Withania somnifera (Ashwagandha) on Hematological and Biochemical Markers, Hormonal Behavior, and Oxidant Response in Healthy Adults: A Systematic Review.

Gomez Afonso A, Fernandez-Lazaro D, Adams D, Monserda-Vilaro A, Fernandez-Lazaro C Curr Nutr Rep. 2023; 12(3):465-477.

PMID: 37428341 PMC: 10444651. DOI: 10.1007/s13668-023-00481-0.


In Silico Study on the Interactions, Molecular Docking, Dynamics and Simulation of Potential Compounds from (L.) Dunal Root against Cancer by Targeting KAT6A.

Deshpande S, Bin Muhsinah A, Bagewadi Z, Ankad G, Mahnashi M, Yaraguppi D Molecules. 2023; 28(3).

PMID: 36770785 PMC: 9920226. DOI: 10.3390/molecules28031117.


References
1.
Pilli R, Naidu M, Pingali U, Shobha J . Evaluation of a new computerized psychometric test battery: Effects of zolpidem and caffeine. J Pharmacol Pharmacother. 2013; 4(4):247-55. PMC: 3826000. DOI: 10.4103/0976-500X.119710. View

2.
Mishra L, Singh B, Dagenais S . Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000; 5(4):334-46. View

3.
Gualtieri C . Computerized neurocognitive testing and its potential for modern psychiatry. Psychiatry (Edgmont). 2011; 1(2):29-36. PMC: 3012617. View

4.
Bhattacharya S, Satyan K, Ghosal S . Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol. 1997; 35(3):236-9. View

5.
Singh N, Bhalla M, de Jager P, Gilca M . An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2012; 8(5 Suppl):208-13. PMC: 3252722. DOI: 10.4314/ajtcam.v8i5S.9. View